Aziyo Biologics in distribution pact with LeMaitre for U.S cardio products

Aziyo Biologics (AZYO) announced it has entered into a distribution agreement with LeMaitre Vascular (LMAT) a provider of vascular devices, implants and services. Under the agreement terms, Aziyo will grant LeMaitre exclusive U.S. distribution rights for the products within its cardiovascular segment: "We are thrilled to collaborate with LeMaitre, an established leader in the vascular space, to distribute our cardiovascular surgery products," said Dr. Randy Mills, President and Chief Executive Officer of Aziyo. "Our products are designed to be highly efficacious across a wide range of applications, and we look forward to expanding their availability by leveraging LeMaitre’s much larger commercial organization. This partnership should increase our operational efficiency as we focus our commercial resources behind our CanGaroo Envelope, which is utilized to help reduce complications associated with implantable electronic devices such as pacemakers, defibrillators and neuromodulation devices."